These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6189902

  • 21. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.
    Brown NA, Miller G.
    J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML, Kwekkeboom J, Goormachtig E, Lindhout E, de Groot C.
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
    [Abstract] [Full Text] [Related]

  • 31. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
    Gallagher G, Stimson WH.
    Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
    [Abstract] [Full Text] [Related]

  • 32. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
    Tsuchiyama L, Kieran J, Boyle P, Wetzel GD.
    Hum Antibodies; 1997 Dec; 8(1):43-7. PubMed ID: 9265505
    [Abstract] [Full Text] [Related]

  • 33. [Preparation of human monoclonal antibodies reactive with human melanoma and the possibility of clinical application].
    Yamaguchi H.
    Gan To Kagaku Ryoho; 1988 May; 15(5):1677-84. PubMed ID: 2835935
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
    Aya T, Mizuno F, Osato T.
    J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
    [Abstract] [Full Text] [Related]

  • 38. Expression of mucin (MUC-1) from a mini-Epstein-Barr virus in immortalized B-cells to generate tumor antigen specific cytotoxic T cells.
    Kilger E, Pecher G, Schwenk A, Hammerschmidt W.
    J Gene Med; 1999 Aug; 1(2):84-92. PubMed ID: 10738572
    [Abstract] [Full Text] [Related]

  • 39. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J, Pai S, Cotter M, Robertson ES.
    Virology; 1999 Sep 15; 262(1):18-30. PubMed ID: 10489337
    [Abstract] [Full Text] [Related]

  • 40. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE, Spits H.
    J Immunol; 1984 Jan 15; 132(1):510-9. PubMed ID: 6197458
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.